Tag Archives: GBCI

Top Safest Stocks To Buy For 2019

One of the most common questions we get on Market Foolery — by far — is how to invest in the increasing legalization of marijuana.

In this episode, Chris Hill talks with analyst David Kretzmann, who just got back from a marijuana conference in Canada, about what the future holds for marijuana companies and the investors who buy their shares. Find out which market trends to keep an eye on as this story plays out, the safest way to stake your bets in this new frontier, how the U.S. legalization question looks right now, and more.

If you want more from The Motley Fool about investing in marijuana, check out fool.ca/marijuanamoment.

A full transcript follows the video.

This video was recorded on June 11, 2018.

Chris Hill: It’s Tuesday, June 12th. Welcome to Market Foolery! I’m Chris Hill. Joining me in studio, it’s David Kretzmann, back from the Great White North.

David Kretzmann: Absolutely!

Hill: Good to see you!

Top Safest Stocks To Buy For 2019: Glacier Bancorp, Inc.(GBCI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Glacier Bancorp (GBCI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Great West Life Assurance Co. Can grew its stake in shares of Glacier Bancorp, Inc. (NASDAQ:GBCI) by 2.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 105,185 shares of the bank’s stock after buying an additional 2,881 shares during the period. Great West Life Assurance Co. Can’s holdings in Glacier Bancorp were worth $4,038,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    News articles about Glacier Bancorp (NASDAQ:GBCI) have trended somewhat positive on Wednesday, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Glacier Bancorp earned a coverage optimism score of 0.10 on Accern’s scale. Accern also gave media headlines about the bank an impact score of 46.4959679542028 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

  • [By Joseph Griffin]

    Swiss National Bank lifted its position in Glacier Bancorp (NASDAQ:GBCI) by 2.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 135,800 shares of the bank’s stock after acquiring an additional 2,900 shares during the period. Swiss National Bank owned about 0.16% of Glacier Bancorp worth $5,212,000 as of its most recent SEC filing.

Top Safest Stocks To Buy For 2019: NeoGenomics, Inc.(NEO)

Advisors’ Opinion:

  • [By Shane Hupp]

    NeoGenomics (NASDAQ:NEO) has been given a consensus recommendation of “Buy” by the twelve ratings firms that are currently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $17.29.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on NeoGenomics (NEO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    NEO (CURRENCY:NEO) traded up 6.9% against the US dollar during the 24 hour period ending at 7:00 AM Eastern on April 15th. NEO has a total market cap of $4.40 billion and $88.39 million worth of NEO was traded on exchanges in the last day. One NEO coin can now be purchased for about $67.68 or 0.00809123 BTC on popular cryptocurrency exchanges including HitBTC, OKEx, Exrates and Upbit. During the last seven days, NEO has traded up 42.9% against the US dollar.

Top Safest Stocks To Buy For 2019: Sypris Solutions Inc.(SYPR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Sypris Solutions, Inc. (NASDAQ: SYPR) is projected to report quarterly loss at $0.07 per share on revenue of $20.35 million.

    Fusion Connect, Inc. (NASDAQ: FSNN) is expected to report quarterly loss at $0.11 per share on revenue of $36.71 million.

Top Safest Stocks To Buy For 2019: Inphi Corporation(IPHI)

Advisors’ Opinion:

  • [By Timothy Green]

    Shares of Inphi Corp. (NYSE:IPHI) dropped on Wednesday following a mixed first-quarter report and a subsequent analyst downgrade. The company’s revenue declined sharply and came in just short of analyst expectations. The stock was down about 9.5% at 2:45 p.m. EDT.

  • [By Max Byerly]

    News coverage about Inphi (NYSE:IPHI) has trended somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Inphi earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned news coverage about the semiconductor company an impact score of 46.0564611984507 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Ezra Schwarzbaum]

    Several other optics stocks stand to gain. In a Monday note, Bank of America Merrill Lynch analyst Vivek Arya also highlighlited the semiconductor space as one that could benefit from the news. Other stocks to watch include:

    Lumentum Holdings Inc (NASDAQ: LITE)
    Ciena Corporation (NYSE: CIEN)
    Coherent, Inc. (NASDAQ: COHR)
    II-VI, Inc. (NASDAQ: IIVI)
    Inphi Corporation (NYSE: IPHI)
    Skyworks Solutions Inc (NASDAQ: SWKS)
    Integrated Device Technology Inc (NASDAQ: IDTI)
    Qorvo Inc (NASDAQ: QRVO)
    Xilinx, Inc. (NASDAQ: XLNX)
    Broadcom Inc (NASDAQ: AVGO)

    Related Links:

  • [By Paul Ausick]

    Inphi Corp. (NYSE: IPHI) fell about 8.6% Friday to post a new 52-week low of $32.36 after closing at $35.40 on Thursday. The 52-week high is $51.78. Volume of about 3 million was roughly five times the daily average of around 680,000 shares traded. The company had no specific news.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Inphi (IPHI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Shares of Inphi Co. (NYSE:IPHI) have been assigned a consensus rating of “Hold” from the sixteen brokerages that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, six have given a hold recommendation and eight have given a buy recommendation to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $38.35.

Top Safest Stocks To Buy For 2019: Becton, Dickinson and Company(BDX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Ferguson Wellman Capital Management Inc. increased its position in Becton Dickinson and Co (NYSE:BDX) by 0.5% in the second quarter, HoldingsChannel.com reports. The firm owned 56,745 shares of the medical instruments supplier’s stock after purchasing an additional 308 shares during the quarter. Ferguson Wellman Capital Management Inc.’s holdings in Becton Dickinson and were worth $13,594,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Levin Capital Strategies L.P. lowered its position in Becton Dickinson and Co (NYSE:BDX) by 0.3% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 49,800 shares of the medical instruments supplier’s stock after selling 150 shares during the quarter. Levin Capital Strategies L.P.’s holdings in Becton Dickinson and were worth $11,221,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Invivo Therapeutics (NASDAQ: NVIV) and Becton Dickinson and (NYSE:BDX) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations and earnings.

  • [By Joseph Griffin]

    McQueen Ball & Associates Inc. decreased its holdings in shares of Becton Dickinson and Co (NYSE:BDX) by 1.9% in the second quarter, Holdings Channel reports. The firm owned 15,033 shares of the medical instruments supplier’s stock after selling 295 shares during the quarter. Becton Dickinson and makes up 2.2% of McQueen Ball & Associates Inc.’s investment portfolio, making the stock its 8th biggest position. McQueen Ball & Associates Inc.’s holdings in Becton Dickinson and were worth $3,601,000 at the end of the most recent reporting period.

  • [By Keith Speights]

    Dividend Yield

    Abbott Laboratories (NYSE:ABT) Drugs $109 billion 19.37 1.88%
    AstraZeneca (NYSE: AZN) Drugs $93 billion 19.70 3.97%
    Becton Dickinson and Co. (NYSE: BDX) Medical supplies $60 billion 17.74 1.29%
    DexCom (NASDAQ: DXCM) Medical devices $8 billion N/A N/A
    Eli Lilly and Co. (NYSE: LLY) Drugs $85 billion 14.91 2.77%
    Insulet (NASDAQ: PODD) Medical devices $5 billion 273.03 N/A
    Johnson & Johnson (NYSE: JNJ) Drugs, medical devices $325 billion 14.16 2.57%
    Lexicon Pharmaceuticals (NASDAQ:LXRX) Drugs $1 billion N/A N/A
    MannKind (NASDAQ: MNKD) Drugs $270 million N/A N/A
    Medtronic (NYSE: MDT) Medical devices $117 billion 15.36 2.14%
    Merck & Co. (NYSE: MRK) Drugs $159 billion 12.99 3.22%
    Novo Nordisk (NYSE:NVO) Drugs $116 billion 18.29 2.61%
    Pfizer (NYSE: PFE) Drugs $209 billion 11.62 3.82%
    Regeneron Pharmaceuticals (NASDAQ: REGN) Drugs $32 billion 13.95 N/A
    Sanofi (NYSE: SNY) Drugs $95 billion 10.75 4.64%
    Senseonics Holdings (NYSEMKT: SENS) Medical devices $447 million N/A N/A
    Tandem Diabetes Care (NASDAQ: TNDM) Medical devices $711 million N/A N/A

    Data source: Yahoo! Finance. P/E = price-to-earnings ratio; N/A = not applicable. Data as of May 25, 2018.